A Case of Systemic Severe Bullous Pemphigoid Caused by Long-Term Sintilimab Treatment for Renal Cell Carcinoma

Immune-related adverse events have been reported in relation to programmed cell death protein-1 (PD-1). However, there are few reports on PD-1 inhibitor-induced bullous pemphigoid. We report the case of a patient who developed bullous pemphigoid following long-term administration of sintilimab for r...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jia, Duan, Xi, Liu, Ting, Yang, Hao, Jiang, Jingjing, Mu, Yunzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375974/
https://www.ncbi.nlm.nih.gov/pubmed/35975195
http://dx.doi.org/10.2147/CCID.S374449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375974/
https://www.ncbi.nlm.nih.gov/pubmed/35975195
http://dx.doi.org/10.2147/CCID.S374449

Ejemplares similares